Cargando…
Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects
Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease belonging to the axial spondyloarthritis (axSpA), a group of diseases that affects the axial skeleton and causes severe pain and disability. An early diagnosis and appropriate treatment can reduce the severity of the disease and...
Autores principales: | Perrotta, Fabio Massimo, Scriffignano, Silvia, Ciccia, Francesco, Lubrano, Ennio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034883/ https://www.ncbi.nlm.nih.gov/pubmed/35469137 http://dx.doi.org/10.2147/OARRR.S295033 |
Ejemplares similares
-
Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016) -
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study
por: Perrotta, Fabio Massimo, et al.
Publicado: (2018) -
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
por: Perrotta, Fabio Massimo, et al.
Publicado: (2022) -
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study
por: Scriffignano, Silvia, et al.
Publicado: (2022) -
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
por: Lubrano, Ennio, et al.
Publicado: (2022)